Tenidap in rheumatoid arthritis a 24‐week double‐blind comparison with hydroxychloroquine‐plus‐piroxicam, and piroxicam alone
Year: 1995
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
Authors: Warren D. Blackburn, H. Malin Prupas, Joel C. Silverfield, Jeffrey E. Poiley, Jacques R. Caldwell, Ronald L. Collins, Michael J. Miller, David H. Sikes, Herbert Kaplan, Roy Fleischmann, Craig D. Scoville, Joel E. Rutstein, Eric R. Hurd, James S. Louie, Arthur D. Bankhurst, Arthur L. Weaver, Anthony I. Sebba, Daniel J. Appelrouth, Norman P. Hudson, Gary V. Gordon, Richard D. Gordon, Charles L. Ludivico, Mitchell C. Austin, Karen M. Sanders, Patrick T. Schuette, Robert A. Moidel, Allen R. Kraska, Naitee Ting, William R. Shanahan, Leland D. Loose
Institutions: University of Alabama at Birmingham, Birmingham VA Medical Center, Halifax Health Medical Center, Denver Arthritis Clinic, Metroplex Clinical Research Center, University of California, Los Angeles, Harbor–UCLA Medical Center, University of New Mexico, United States Department of Veterans Affairs, Veterans Health Administration, Hunter Holmes McGuire VA Medical Center, Pfizer (United States)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2012516397